YOU CAN NOW DISCUSS THIS PERSON ON OUR FORUM JUST
CLICK HERE!
HELP US TO CREATE HUMAN ENCYCLOPEDIA.
YOU CAN EDIT THIS PERSON'S DATA JUST CLICK HERE!
HELP US TO CREATE HUMAN ENCYCLOPEDIA.
YOU CAN EDIT THIS PERSON'S DATA JUST CLICK HERE!
Carlos M Galmarini
Person Category: World Scientists
Abstract
Objects related with this person
Potential mechanisms of resistance to cytarabine in AML patients.
In vivo mechanisms of resistance to cytarabine in acute myeloid leukaemia.
Nucleoside analogues and nucleobases in cancer treatment.
P-glycoprotein expression by cancer cells affects cell cytotoxicity and cell-cycle perturbations induced by six chemotherapeutic drugs.
Role of IMP-selective 5'-nucleotidase (cN-II) in hematological malignancies.
Pyrimidine nucleoside analogs in cancer treatment.
In vitro susceptibility of CD4(+) and CD8(+) T cell subsets to fludarabine.
Frameshift mutation in the Dok1 gene in chronic lymphocytic leukemia.
OSI-461 (OSI).
Characterization of a gemcitabine-resistant murine leukemic cell line: reversion of in vitro resistance by a mononucleotide prodrug.
Problems related to resistance to cytarabine in acute myeloid leukemia.
Quantitative analysis of nucleoside transporter and metabolism gene expression in chronic lymphocytic leukemia (CLL): identification of fludarabine-sensitive and -insensitive populations.
Histamine dihydrochloride (subcutaneous) Maxim.
[Metabolism, mechanism of action and resistance to cytotoxic nucleoside analogues]
Increased expression of the large subunit of ribonucleotide reductase is involved in resistance to gemcitabine in human mammary adenocarcinoma cells.
F-ara-AMP is a substrate of cytoplasmic 5'-nucleotidase II (cN-II): HPLC and NMR studies of enzymatic dephosphorylation.
Drug evaluation: sapacitabine--an orally available antimetabolite in the treatment of cancer.
Correlation of hENT1 expression and function with gemcitabine cytotoxicity in mantle cell lymphoma lines and clinical samples.
Related people:
Sanghoon Lee
Jocelyne Michelon
Bakary S Sylla
Rosita Accardi
Fabien Calvo
James D Young
Carol E Cass
Xavier Thomas
Mirta Giordano
Romina Gamberale
Paula Fernández-Calotti
Lars Jordheim
Emeline Cros
John R Mackey
Charles Dumontet
Laith Dabbagh
John Mackey
Muriel Rabilloud
Raymond Lai
John Hanson
Jean-Marc Lancelin
Philippe Rousselot
Jacques L Binet
Marie-Claude Gagnieu
Isabelle Krimm
François Roy
Carlos M Galmarini
Alexandra Viller
Olivier Guittet
Michel Lepoivre
Alain Delmer
Jorge Geffner
Thack Lang
Julio Sánchez-Avalos
Christian Perigaud
Lawrence D Jewell
Helene Merle-Béral
Suzanne Peyrottes
Assia El Jafaari
Assia El Jaffari
Lars Petter Jordheim
Darryl Glubrecht
Kathryn A Graham
Anil A Joy
Lars P Jordheim
Marie-Hélène Gouy
Anne-Sophie Bretonnet
Potential mechanisms of resistance to cytarabine in AML patients.
In vivo mechanisms of resistance to cytarabine in acute myeloid leukaemia.
Nucleoside analogues and nucleobases in cancer treatment.
P-glycoprotein expression by cancer cells affects cell cytotoxicity and cell-cycle perturbations induced by six chemotherapeutic drugs.
Role of IMP-selective 5'-nucleotidase (cN-II) in hematological malignancies.
Pyrimidine nucleoside analogs in cancer treatment.
In vitro susceptibility of CD4(+) and CD8(+) T cell subsets to fludarabine.
Frameshift mutation in the Dok1 gene in chronic lymphocytic leukemia.
OSI-461 (OSI).
Characterization of a gemcitabine-resistant murine leukemic cell line: reversion of in vitro resistance by a mononucleotide prodrug.
Problems related to resistance to cytarabine in acute myeloid leukemia.
Quantitative analysis of nucleoside transporter and metabolism gene expression in chronic lymphocytic leukemia (CLL): identification of fludarabine-sensitive and -insensitive populations.
Histamine dihydrochloride (subcutaneous) Maxim.
[Metabolism, mechanism of action and resistance to cytotoxic nucleoside analogues]
Increased expression of the large subunit of ribonucleotide reductase is involved in resistance to gemcitabine in human mammary adenocarcinoma cells.
F-ara-AMP is a substrate of cytoplasmic 5'-nucleotidase II (cN-II): HPLC and NMR studies of enzymatic dephosphorylation.
Drug evaluation: sapacitabine--an orally available antimetabolite in the treatment of cancer.
Correlation of hENT1 expression and function with gemcitabine cytotoxicity in mantle cell lymphoma lines and clinical samples.
Related people:
Sanghoon Lee
Jocelyne Michelon
Bakary S Sylla
Rosita Accardi
Fabien Calvo
James D Young
Carol E Cass
Xavier Thomas
Mirta Giordano
Romina Gamberale
Paula Fernández-Calotti
Lars Jordheim
Emeline Cros
John R Mackey
Charles Dumontet
Laith Dabbagh
John Mackey
Muriel Rabilloud
Raymond Lai
John Hanson
Jean-Marc Lancelin
Philippe Rousselot
Jacques L Binet
Marie-Claude Gagnieu
Isabelle Krimm
François Roy
Carlos M Galmarini
Alexandra Viller
Olivier Guittet
Michel Lepoivre
Alain Delmer
Jorge Geffner
Thack Lang
Julio Sánchez-Avalos
Christian Perigaud
Lawrence D Jewell
Helene Merle-Béral
Suzanne Peyrottes
Assia El Jafaari
Assia El Jaffari
Lars Petter Jordheim
Darryl Glubrecht
Kathryn A Graham
Anil A Joy
Lars P Jordheim
Marie-Hélène Gouy
Anne-Sophie Bretonnet
Created
2006-12-17 22:17:21
Comments
0
Hits
23
Related
46
Objects
18
